There are currently 80 active clinical trials seeking participants for Diabetes research studies. The states with the highest number of trials for Diabetes participants are California, Texas, Florida and Pennsylvania.
Efficacy of Suvorexant in the Treatment of Insomnia in Midlife Women With Pre-Diabetes
NCT05593653
Recruiting
The aim of this study is to determine if suvorexant can help treat the severity of insomnia in midlife women who are pre-diabetic.
Gender:
Female
Ages:
Between 40 years and 65 years
Trial Updated:
02/16/2023
Locations: Brigham and Women's Hospital, Boston, Massachusetts
Conditions: Insomnia, Diabetes, Menopause
Register for Updates
Uric Acid Lowering Trial in Youth Onset T2D
NCT03899883
Recruiting
Adolescents and young adults with youth-onset type 2 diabetes (T2D) are disproportionally impacted by hyperuricemia compared to non-diabetic peers and youth with type 1 diabetes (T1D). In fact, 50% of males with youth-onset T2D have serum uric acid (SUA) greater than 6.8 mg/dl. The investigators also recently demonstrated that higher SUA conferred greater odds of developing hypertension and diabetic kidney disease (DKD) in youth with T2D over 7 years follow-up. Elevated SUA is thought to lead to... Read More
Gender:
Male
Ages:
Between 18 years and 25 years
Trial Updated:
02/07/2023
Locations: Children's Hospital Colorado, Aurora, Colorado
Conditions: Diabetic Kidney Disease, Hyperuricemia, Diabetes, Diabetes Mellitus, Type 2, Type2 Diabetes, Type 2 Diabetes Mellitus, Diabetic Nephropathies, Diabetes Complications
Register for Updates
Mitigating the Pro-inflammatory Phenotype of Obesity
NCT04934228
Recruiting
The purpose of this study is to examine the hypothesize that 4 weeks of sympathetic nerve activity (SNA) inhibition (oral clonidine) will cause a significant reduction in circulating blood concentrations and endothelial cell expression of inflammatory markers (e.g., TNF-α, IL-6). Our study is a prospective study using a randomized, double-blinded design to test 4 weeks of SNA blockade (oral clonidine) compared with a BP-lowering control condition (diuretic, hydrochlorothiazide) or a placebo.
Gender:
All
Ages:
Between 18 years and 79 years
Trial Updated:
06/15/2022
Locations: University of Kansas Medical Center, Kansas City, Kansas
Conditions: Blood Pressure, Diabetes, Obesity, Insulin Resistance, Diuretics Drug Reactions, Sympathetic Nerve Activity
Register for Updates
Clinical Investigation of K'Watch - Lab & Home Study
NCT05093569
Recruiting
This study categorized as a non significant risk trial is a monocentric, prospective, open-label comparative, paired-design trial aims to evaluate the performance and the tolerance of K'Watch CGM system in comparison with conventional reference (YSI system, BGM system and CGM systems ) . This trial will be conducted on patients with Type 1 and 2 of diabetes for 8 days.
Gender:
All
Ages:
Between 18 years and 80 years
Trial Updated:
04/25/2022
Locations: AMCR Institute, San Diego, California
Conditions: Diabetes
Register for Updates
Imaging Histone Deacetylase in the Heart
NCT03549559
Recruiting
The overall goal of this PET-MR imaging trial is to evaluate 11C-Martinostat, a histone deacetylase targeted radioligand, in patients with aortic stenosis, individuals with diabetes, and healthy volunteers.
Gender:
All
Ages:
Between 18 years and 85 years
Trial Updated:
03/01/2022
Locations: Massachusetts General Hospital, Boston, Massachusetts
Conditions: Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis, Diabetes
Register for Updates
Continuous Monitoring and Control of Hypoglycemia
NCT03340831
Recruiting
Evaluate safety of non-adjunctive CGM use in CGM naive participants.
Gender:
All
Ages:
2 years and above
Trial Updated:
09/17/2021
Locations: Scripps Whittier Diabetes Institute, La Jolla, California +24 locations
Conditions: Diabetes
Register for Updates
Randomized Trial of Exercise Promotion in Primary Care
NCT04445168
Recruiting
Millions of Americans have diabetes or prediabetes, for which regular physical activity can reduce risks of unfavorable outcomes of these conditions. This study will test the effects of an evidence-based intervention in the primary care setting on increasing physical activity among these individuals. If effective, it can be broadly implemented in primary care.
Gender:
All
Ages:
Between 18 years and 74 years
Trial Updated:
07/27/2021
Locations: Kaiser Permanente Southern California, Pasadena, California
Conditions: PreDiabetes, Diabetes, Sedentary Behavior
Register for Updates
Glucose Differences Between the Left Arm and Right Arm in Diabetic Patients Using a Continuous Glucose Monitor
NCT04790760
Recruiting
Continuous glucose monitoring (CGM) is an emerging field for diabetes management. CGMs are small devices primarily placed on a patient's upper arm that allow providers and patients to individualize therapy by looking at real time glucose levels. While the accuracy of these devices is extensively researched, there are no large-scale studies evaluating the differences between left and right arm glucose readings in the diabetic population. Additionally cinnamon and aloe vera are supplements commonl... Read More
Gender:
All
Ages:
Between 18 years and 65 years
Trial Updated:
03/05/2021
Locations: Manshadi Heart Institute, Inc., Stockton, California
Conditions: Diabetes
Register for Updates